Related Experiment Video
Updated: May 20, 2025

07:43
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
26.3K
Hormonal and neuronal interactions shaping the brain metastatic microenvironment.
Stephen Shovlin1, Leonie S Young2, Damir Varešlija3
1School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Cancer Letters
|April 27, 2025
Summary
Brain metastases (BrM) are a major challenge in cancer. This review explores how hormones and neuroendocrine-immune interactions in the brain may fuel BrM growth, suggesting new therapeutic targets.
Area of Science:
- Neuroscience
- Oncology
- Endocrinology
Background:
- Metastatic progression, particularly to the central nervous system (CNS), is a leading cause of cancer mortality.
- Brain metastases (BrM) from lung, breast, and melanoma cancers have poor prognoses, despite advances in treating extracranial tumors.
- The increasing incidence of BrM highlights gaps in understanding CNS tumor biology and colonization.
Purpose of the Study:
- To review the hormonal landscape of the adult brain in the context of cancer neuroscience.
- To examine how neuroendocrine-immune interactions, influenced by sex hormones, may promote metastatic growth within the CNS.
- To identify novel therapeutic opportunities by understanding the interplay between hormones and tumor adaptation.
Main Methods:
- Literature review of existing research on brain metastases, cancer neuroscience, and hormonal regulation in the CNS.
- Analysis of the role of sex steroids and neurosteroids in the brain microenvironment.
- Exploration of neuroendocrine-immune interactions and their influence on tumor growth.
Main Results:
- Steroid hormones can cross the blood-brain barrier or be synthesized within the CNS, affecting inflammation, synaptic plasticity, and immune surveillance.
- Hormonal pathways normally involved in brain function may be co-opted by cancer cells to support colonization and growth.
- The interplay between systemic hormones, local steroidogenesis, and tumor adaptation is crucial for BrM development.
Conclusions:
- Understanding the brain's hormonal milieu is critical for addressing the challenges of brain metastases.
- Neuroendocrine-immune pathways represent promising targets for novel therapeutic strategies against BrM.
- Further research into hormone-tumor interactions in the CNS can lead to improved patient outcomes.
Related Concept Videos
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Neurotransmitters
752
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
752
Regulation of Hormone Secretion
3.0K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
Humoral...
3.0K
Target Cell Response to Hormones
2.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
2.8K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K

